KR20200002576U - Equipment for applying medicines in the oral cavity - Google Patents

Abstract

In accordance with an embodiment of the present disclosure, a drug oral application device is disclosed. The drug ward applicator includes: an applicator having a polygonal column shape and having an insertion portion at a lower portion thereof; A user-graspable handle portion; A support portion having a coupling portion inserted into the insertion portion at one end, and a support portion having the other end opposite to the one end coupled to the handle portion, wherein the coupling portion includes: a support member having a first diameter; A spherical member provided at one end of the support member; A plurality of first protrusions provided below the spherical member and protruding from the support member so as to have a second diameter larger than the first diameter; A locking portion provided below the plurality of first protrusions, protruding from the support member, and having an inclined surface inclined downward; And a second protrusion provided below the locking part and protruding from the support member so as to have a third diameter larger than the second diameter.

Description

EQUIPMENT FOR APPLYING MEDICINES IN THE ORAL CAVITY}

The present disclosure relates to a drug ward application device, and more specifically, to a drug ward application device including a polygonal columnar application unit.

For many years, studies on the causes of in-hospital aspiration pneumonia in long-term inpatients and ventilators have been continued. As a result, research results have been reported that the incidence of aspiration pneumonia in hospitals can be reduced through professional oral hygiene management in long-term hospitalized patients, and this has been published several times in related papers.

As the need for professional oral care increases, hospitals in many foreign countries have been treating it for a long time, and recently, a large number of hospitals in Korea are carrying out such specialized oral care.

However, in the process of carrying out the oral care, professional treatment equipment has not been approved, so there is no choice but to proceed with a very inappropriate treatment.

For example, a treatment method currently underway in Korea involves wrapping gauze around a plastic forceps in a disposable dressing kit, but this may cause a wound in the oral cavity due to the shape of the forceps. As another example, the treatment is carried out by wrapping gauze around the tip of the tongue depressor, but due to the dull shape of the tongue depressor, it is difficult to manage fine parts in the oral cavity.

Meanwhile, the market of high-function and high-value-added products related to oral health is expanding against the backdrop of rising consumer interest in oral health. In particular, the market size of oral care products for elderly care, which is expected to expand due to the increase in the elderly population and home care, is gradually expanding.

As described above, at present, without special equipment, after applying a cleaning solution to the oral mucosa, tongue, teeth, and gums of the patient for oral care, the corresponding area is sterilized and washed. For example, for oral care, gauze is rolled on a rod (eg, medical forceps or tongue depressor) and sterilization is performed.

In this case, due to the size of the gauze, there is a problem that it is not easy to apply and clean the cleaning solution to a portion deep from the opening such as the mucous membrane of the oral cavity, the gums of the molars, and the teeth. In addition, there is a problem that the gauze is easily peeled off the rod, and the mucous membrane in the oral cavity is damaged due to the pointed end of the medical forceps or the tip of the tongue depressor, and bleeding occurs very often. . In addition, patients who cannot open their mouths (e.g., unconscious patients) are treated with a separate opening device, and in this case, the range of applying and sterilizing cleaning solutions using conventional methods is very limited. There is a problem.

Accordingly, Korean Utility Model Publication No. 20-0468339 (2013.08.07) discloses an oral care device having a tongue washing means. However, the prior art is a design improved from a general toothbrush, and can be used for the purpose of washing the user's own oral cavity for oral management. That is, the oral care apparatus according to the prior art may be unsuitable for use by a doctor or a caregiver to treat a patient.

Therefore, there is a demand for specialized instruments to facilitate the treatment that a doctor or caregiver performs on a patient for oral care.

The present disclosure is conceived in response to the above-described background technology, and is intended to provide an intramedicinal application device that is safe, convenient, and capable of detailed treatment.

The technical problems of the present disclosure are not limited to the technical problems mentioned above, and other technical problems that are not mentioned will be clearly understood by those skilled in the art from the following description.

According to an embodiment of the present disclosure for solving the problems as described above, a drug ward application mechanism is disclosed. The drug ward applicator includes: an applicator having a polygonal column shape and having an insertion portion at a lower portion thereof; A user-graspable handle portion; And a support part having a coupling part inserted into the insertion part at one end, and having the other end opposite to the one end connected to the handle part, wherein the coupling part comprises: a support member having a first diameter; A spherical member provided at one end of the support member; A plurality of first protrusions provided below the spherical member and protruding from the support member so as to have a second diameter larger than the first diameter; A locking portion provided below the plurality of first protrusions, protruding from the support member, and having an inclined surface inclined downward; And a second protrusion provided below the locking part and protruding from the support member so as to have a third diameter larger than the second diameter.

In addition, the insertion part may include a cutout groove cut to have a one (一) shape in the center of the lower surface, and a depth of the cutout groove may correspond to a length of the coupling part.

In addition, the coupling portion may be adhesively bonded to the insertion portion through a silicone adhesive while being inserted into the insertion portion.

In addition, the handle portion may be formed in a cylindrical shape having a fourth diameter larger than the diameter of the support portion.

In addition, the handle part may include a grip part that prevents rotation when the user grips it, and the grip part may form a gripping part that is curved to be in close contact with the index finger and thumb on both sides.

In addition, the applicator may be made of a foam made of polyurethane, and absorb and discharge the solution of the medicine.

In addition, the support may be made of a plastic material blended with 60 parts by weight of polycarbonate and 40 parts by weight of ABS resin (Acrylonitrile-Butadiene-Styrene Copolymer).

In addition, the cut groove may be formed to have a length of 6.6 mm or more and 7.7 mm or less.

In addition, the support portion may be formed to have a length of 139.5 mm or more and 170.5 mm or less, and may be formed to have a diameter of 3.6 mm or more and 4.4 mm or less.

In addition, the user-graspable handle portion may be formed to have a diameter of 5.4 mm or more and 6.6 mm or less.

In addition, the support member is formed to have a diameter of 3.6 mm or more and 4.4 mm or less, the spherical member is formed to have a diameter of 5.4 mm or more and 6.6 mm or less, and the first protrusion is 5.4 mm or more , Is formed to have a diameter of 6.6 mm or less, and the second protrusion may be formed to have a diameter of 7.2 mm or more and 8.8 mm or less.

In addition, the plurality of first protrusions may be spaced apart from each other to have a spacing of 1.08 mm or more and 1.32 mm or less to protrude from the support member.

Technical solutions obtainable in the present disclosure are not limited to the above-mentioned solutions, and other solutions that are not mentioned are clearly to those of ordinary skill in the technical field to which the present disclosure belongs from the following description. It will be understandable.

The present disclosure can provide a device for intramedicine application that is safe, convenient, and capable of detailed treatment.

The effects obtainable in the present disclosure are not limited to the effects mentioned above, and other effects not mentioned will be clearly understood by those of ordinary skill in the art from the following description. .

Various aspects are now described with reference to the drawings, wherein like reference numbers are used collectively to refer to like elements. In the examples that follow, for illustrative purposes, a number of specific details are presented to provide a holistic understanding of one or more aspects. However, it will be apparent that such aspect(s) may be practiced without these specific details.
1 is a perspective view of a drug oral application device according to some embodiments of the present disclosure.
2 is a diagram illustrating a lower surface of an applicator according to some embodiments of the present disclosure.
3 is a view showing a side of a support according to some embodiments of the present disclosure.
4 is a view showing another side of a support according to some embodiments of the present disclosure.
5 is a three-dimensional view of a support according to some embodiments of the present disclosure.
6 is a view for explaining a method of coupling an applicator and a support included in a drug ward applicator according to some embodiments of the present disclosure.

Various embodiments and/or aspects are now disclosed with reference to the drawings. In the following description, for illustrative purposes, a number of specific details are disclosed to aid in an overall understanding of one or more aspects. However, it will also be appreciated by those of ordinary skill in the art that this aspect(s) may be practiced without these specific details. The following description and the annexed drawings set forth in detail certain illustrative aspects of one or more aspects. However, these aspects are exemplary and some of the various methods in the principles of the various aspects may be used, and the descriptions described are intended to include all such aspects and their equivalents.

As used herein, “an embodiment,” “example,” “aspect,” “example,” and the like may not be construed as having any aspect or design described as being better or advantageous than other aspects or designs. .

In addition, the term “or” is intended to mean an inclusive “or” rather than an exclusive “or”. That is, unless specified otherwise or is not clear from the context, "X employs A or B" is intended to mean one of the natural inclusive substitutions. That is, X uses A; X uses B; Or, when X uses both A and B, “X uses A or B” can be applied to either of these cases. In addition, the term "and/or" as used herein should be understood to refer to and include all possible combinations of one or more of the listed related items.

In addition, the terms "comprising" and/or "comprising" mean that the corresponding feature and/or element is present, but excludes the presence or addition of one or more other features, elements and/or groups thereof. It should be understood as not. In addition, unless otherwise specified or when the context is not clear as indicating a singular form, the singular in the specification and claims should be interpreted as meaning "one or more" in general.

Hereinafter, the same or similar components are assigned the same reference numerals regardless of the reference numerals, and redundant descriptions thereof will be omitted. In addition, in describing the embodiments disclosed in the present specification, when it is determined that detailed descriptions of related known technologies may obscure the subject matter of the embodiments disclosed in the present specification, detailed descriptions thereof will be omitted. In addition, the accompanying drawings are for easy understanding of the embodiments disclosed in the present specification, and the technical spirit disclosed in the present specification is not limited by the accompanying drawings.

Although the first, second, and the like are used to describe various devices or components, it goes without saying that these devices or components are not limited by these terms. These terms are only used to distinguish one device or component from another device or component. Therefore, it goes without saying that the first element or element mentioned below may be a second element or element within the spirit of the present disclosure.

Unless otherwise defined, all terms (including technical and scientific terms) used in the present specification may be used as meanings that can be commonly understood by those of ordinary skill in the art to which this disclosure belongs. In addition, terms defined in a commonly used dictionary are not interpreted ideally or excessively unless explicitly defined specifically.

When a component is referred to as being "connected" or "connected" to another component, it is understood that it is directly connected to or may be connected to the other component, but other components may exist in the middle. Should be. On the other hand, when a component is referred to as being "directly connected" or "directly connected" to another component, it should be understood that there is no other component in the middle.

When an element or layer is referred to as “on” or “on” of another element or layer, it is not only above the other element or layer, but also the other layer or other element in the middle. Includes all intervening cases. On the other hand, when a component is referred to as "directly on" or "directly on", it means that no other component or layer is interposed therebetween.

Spatially relative terms "below", "beneath", "lower", "above", "upper", etc., as shown in the figure It can be used to easily describe a component or a correlation with other components. Spatially relative terms should be understood as terms including different directions of the device during use or operation in addition to the directions shown in the drawings.

For example, if a component shown in a drawing is turned over, a component described as "below" or "beneath" of another component will be placed "above" the other component. I can. Accordingly, the exemplary term “below” may include both directions below and above. Components may be oriented in other directions, and thus spatially relative terms may be interpreted according to the orientation.

Objects and effects of the present disclosure, and technical configurations for achieving them will become apparent with reference to embodiments described in detail later with reference to the accompanying drawings. In describing the present disclosure, when it is determined that a detailed description of a well-known function or configuration may unnecessarily obscure the subject matter of the present disclosure, a detailed description thereof will be omitted. In addition, terms to be described later are terms defined in consideration of functions in the present disclosure and may vary according to the intention or custom of users or operators.

However, the present disclosure is not limited to the embodiments disclosed below, and may be implemented in various different forms. The present embodiments are provided only to make the present disclosure complete, and to completely inform the scope of the disclosure to those of ordinary skill in the art to which the present disclosure belongs, and the present disclosure is only defined by the scope of the claims. . Therefore, the definition should be made based on the contents throughout this specification.

1 is a perspective view of a drug oral application device according to some embodiments of the present disclosure.

Referring to FIG. 1, the drug application device 1000 may include an applicator 100, a support 200, and a handle 300. However, the above-described components are not essential in forming the drug ward application device 1000, so the drug ward application device 1000 may have more or less components than the above-listed components. .

The intra-medicine application device 1000 may refer to a device used to perform treatments such as oral washing and moisturizing cloth for long-term hospitalized patients and patients wearing artificial respirators. However, the present invention is not limited thereto, and the drug ward application device 1000 may collectively refer to a device used when applying various drugs to the ward.

Meanwhile, the applicator 100 may mean a portion capable of absorbing and discharging a solution of a drug.

According to some embodiments of the present disclosure, the application unit 100 may have a polygonal column shape. Specifically, the applicator 100 may have a square pillar shape having an uneven pattern on the side surface. That is, the applicator 100 may have a rectangular parallelepiped shape with an uneven pattern on the side surface. However, the present invention is not limited thereto, and the application part 100 may have a shape in which an uneven pattern is provided on a circular column.

More specifically, the applicator 100 may have a central portion of a rectangular parallelepiped shape having an upper surface, a lower surface, a first side, a second side, a third side and a fourth side. Further, an uneven pattern may be provided on each of the first side, the second side, the third side and the fourth side of the center. That is, the central portion of the applicator 100 may include a convex portion protruding outward on each of the first side, the second side, the third side and the fourth side.

Accordingly, the application unit 100 may have an uneven pattern on each of the first side, the second side, the third side and the fourth side. And, the convex portion may be provided in the vertical direction. In addition, the central portion and the convex portion may be integrally formed.

Meanwhile, the convex portion may be disposed at the center of each of the first side, the second side, the third side and the fourth side of the center of the application portion 100. The size of the upper and lower surfaces of the convex portion may be smaller than the size of the upper and lower surfaces of the center. And, the height of the convex portion may be the same as the height of the center. In this way, the convex portion of the application unit 100 is provided on each of the four side surfaces of the central portion of the application unit 100 so that the application unit 100 can have an uneven pattern on each side surface.

Meanwhile, the applicator 100 may have the same polygonal shape (eg, a quadrangle) in the upper and lower surfaces excluding the side surfaces. That is, the shape of the polygonal column of the application unit 100 may have a step shape when viewed from the side.

Therefore, when the applicator 100 has a polygonal column shape as described above, a therapist who uses the intraoral applicator 1000 may apply or wash the medication in detail to the corners of the patient's oral cavity.

In particular, when the applicator 100 has a polygonal column shape as described above, treatment for the outer gum in the oral cavity can be easily performed. In addition, when the applicator 100 has a polygonal column shape as described above, treatment for external teeth in the oral cavity may also be easily performed.

Meanwhile, the applicator 100 may have an insertion portion underneath. In this case, the application part 100 may be fitted to the support part 200 through an insertion part provided at the lower part.

The insertion part provided in the application part 100 may include a cutout groove cut to have a one (一) shape in the center of the lower surface. However, the present invention is not limited thereto, and the cut groove 111 may have a cylindrical shape corresponding to the diameter of the coupling portion 210.

A description of the insertion part provided in the above-described application part 100 will be described later in detail with reference to FIG. 2.

On the other hand, the application unit 100 is made of a foam (Form) made of a polyurethane (Polyurethane) material, it is possible to absorb and discharge the solution of the drug. As described above, when the application part 100 is made of a foam made of a polyurethane material, the solution of the medicine can be easily absorbed and discharged from other materials. However, the present invention is not limited thereto, and the application part 100 may be formed of various materials.

According to some embodiments of the present disclosure, the support part 200 may have a coupling part inserted into the insertion part of the application part 100 at one end. In addition, the support part 200 may be coupled with a handle part 300 that can be gripped by a user at the other end opposite to the one end.

According to some embodiments of the present disclosure, the support part 200 may be integrally formed with the coupling part and the handle part. However, the present invention is not limited thereto, and the support part 200 may be formed in a form separated from the coupling part and the handle part, and may be manufactured in a form capable of being assembled when used.

The coupling part provided in the support part 200 may include a support member, a spherical member, a plurality of first protrusions, a locking part, and a second protrusion.

A description of the coupling part provided in the above-described support part 200 will be described later in more detail with reference to FIGS. 3 to 5.

Meanwhile, the support part 200 may be made of a plastic material mixed with 60 parts by weight of polycarbonate and 40 parts by weight of ABS resin (Acrylonitrile-Butadiene-Styrene Copolymer). However, the present invention is not limited thereto, and the support part 200 may be formed of various materials. As described above, when the support part 200 is made of a plastic material mixed with 60 parts by weight of polycarbonate and 40 parts by weight of ABS resin, the elasticity of the plastic material may be improved.

According to some embodiments of the present disclosure, each of the application unit 100 and the support unit 200 may be sterilized and packaged to be provided to the user in the drug oral application device 1000. Here, the support part 200 may be an integral type in which the coupling part and the handle part 300 are each combined. However, it is not limited thereto.

Meanwhile, the handle part 300 coupled to the other end of the support part 200 may include a grip part that prevents rotation when the user grips it. A description of the handle part will be described later in more detail with reference to FIG. 5.

In the case of using the intramedicinal application device 1000 according to some embodiments of the present disclosure described above, it is safer, more convenient, and more detailed treatment than the existing treatment method, as well as long-term inpatients and respirators May reduce the incidence of aspiration pneumonia.

2 is a diagram illustrating a lower surface of an applicator according to some embodiments of the present disclosure.

Referring to FIG. 2, the application unit 100 may include an insertion unit 110. Here, the insertion unit 110 may include an incision groove 111 cut to have a one (一) shape in the center of the lower surface. However, the present invention is not limited thereto, and the cut groove 111 may have a cylindrical shape corresponding to the diameter of the coupling portion 210.

The cut groove 111 may be formed to have a length of 6.6 mm or more and 7.7 mm or less. Preferably, the cut groove 111 may be formed to have a length of 7mm. However, the length of the cut groove 111 is not limited thereto, and the length of the cut groove 111 may be manufactured to correspond to the diameter of the coupling portion 210 coupled to the application unit 100.

Therefore, when the application part 100 and the coupling part 210 are combined, the size of each of the coupling part 210 of the insertion part 110 and the support part 200 of the application part 100 (here, incision length and diameter) It can prevent the phenomenon of tearing due to differences.

When the cutting groove 111 included in the insertion part 110 is combined with the coupling part 210 of the support part 200, it may be opened. When the cutting groove 111 is open, the coupling portion 210 may be inserted into the cutting groove 111.

Meanwhile, the depth of the incision groove 111 may correspond to the length of the coupling portion 210 provided in the support portion 200. That is, the coupling portion 210 of the support portion 200 may be inserted into the cut groove 111 by the length of the insertion portion 110 of the application portion 100.

Therefore, the coupling portion 210 may not penetrate the application portion 100. In addition, it is possible to prevent the occurrence of damage to the mucous membrane in the oral cavity through one end of the support part 200 penetrating the application part.

Meanwhile, the applicator 100 may be formed in a polygonal column shape (a polygonal bottom surface). Accordingly, as shown in FIG. 2, the lower surface of the application unit 100 may have a quadrangular shape in which the uneven pattern is provided on four side surfaces.

More specifically, the applicator 100 may have a central portion of a rectangular parallelepiped shape having an upper surface, a lower surface, a first side, a second side, a third side and a fourth side. Further, an uneven pattern may be provided on each of the first side, the second side, the third side and the fourth side of the center. That is, the central portion of the applicator 100 may include a convex portion protruding outward on each of the first side, the second side, the third side and the fourth side. Accordingly, the application unit 100 may have an uneven pattern on each of the first side, the second side, the third side and the fourth side. And, the convex portion may be provided in the vertical direction. Accordingly, the lower surface may have a quadrangular shape in which a step-shaped irregular pattern is provided on four side surfaces.

Meanwhile, the convex portion may be disposed at the center of each of the first side, the second side, the third side and the fourth side of the center of the application portion 100. The size of the upper and lower surfaces of the convex portion may be smaller than the size of the upper and lower surfaces of the center. And, the height of the convex portion may be the same as the height of the center. In this way, the convex portion of the application unit 100 is provided on each of the four side surfaces of the central portion of the application unit 100 so that the application unit 100 can have an uneven pattern on each side surface. Accordingly, the lower surface may have a quadrangular shape having a step-shaped uneven pattern on four side surfaces.

In the case where the applicator 100 has a polygonal column shape as described above, a therapist who uses the applicator 1000 in the drug premises may apply or clean the drug to a corner of the patient's oral cavity.

Particularly, when the applicator 100 has a polygonal column shape as described above, a therapist using the intramedicinal applicator 1000 can easily perform treatment on the external gums in the oral cavity of the patient.

In addition, when the applicator 100 has a polygonal column shape as described above, a therapist who uses the intraoral applicator 1000 can also easily treat the external teeth in the oral cavity of the patient.

3 is a view showing a side of a support according to some embodiments of the present disclosure. 4 is a view showing another side of a support according to some embodiments of the present disclosure. 5 is a three-dimensional view of a support according to some embodiments of the present disclosure.

3 to 5, the support part 200 may include a coupling part 210 at one end. In addition, the support part 200 may have the other end opposite to one end coupled to the handle part 300.

According to some embodiments of the present disclosure, the support part 200 may be integrally formed with the coupling part 210 and the handle part 300. However, the present invention is not limited thereto, and the support part 200 is formed in a form separated from the coupling part 210 and the handle part 300, and may be manufactured in a form that can be assembled when used.

The support part 200 may be formed to have a length of 139.5 mm or more and 170.5 mm or less. Preferably, the support part 200 may be formed to have a length of 153mm. In addition, the support part 200 may be formed to have a diameter of 3.6 mm or more and 4.4 mm or less. Preferably, the support part 200 may be formed to have a diameter of 4mm.

The coupling part 210 provided at one end of the support part 200 may include a support member 211 having a first diameter.

Specifically, the support member 211 may be formed to have a diameter of 3.6 mm or more and 4.4 mm or less. Preferably, the support member 211 may be formed to have a diameter of 4mm.

The coupling part 210 may include a spherical member 212 at one end of the support member 211.

As shown in Fig. 5, when the spherical member 212 is provided at one end of the support member 211, it is possible to prevent damage to the mucous membrane in the patient's oral cavity when the therapist applies the medicine to the patient's oral cavity. Can be prevented.

Specifically, even if the application portion 100 coupled to the coupling portion 210 is torn or separated, only the spherical member 212 provided at one end of the coupling portion 210 is exposed to the outside. Further, since the spherical member 212 does not have a sharp portion, even if the spherical member 212 is exposed, it is possible to prevent damage to the mucous membrane in the oral cavity of the patient when the therapist applies the medicine to the oral cavity of the patient.

Meanwhile, the spherical member 212 may be formed to have a diameter of 5.4 mm or more and 6.6 mm or less. Preferably, the spherical member 212 may be formed to have a diameter of 6mm. In addition, as described above in FIG. 2, the cut groove 111 may be formed to have a length of 6.6 mm or more and 7.7 mm or less. Accordingly, when the spherical member 212 is inserted into the cut groove, the phenomenon that the coating unit 100 is torn can be prevented.

On the other hand, the coupling part 210 may include a plurality of first protrusions 213. Here, the plurality of first protrusions 213 may be provided below the spherical member 212.

The number of the plurality of first protrusions 213 may be 2 to 4. However, the number of the plurality of first protrusions 213 is not limited thereto, and the number of the plurality of first protrusions 213 may be increased depending on the difficulty of manufacturing or the overall size of the application device 1000 in the drug ward.

In addition, each of the plurality of first protrusions 213 may have a second diameter larger than the first diameter of the support member 211. Accordingly, each of the plurality of first protrusions 213 may protrude outward from the support member 211.

Meanwhile, each of the plurality of first protrusions 213 may be spaced apart from each other to have a specific interval. Specifically, each of the plurality of first protrusions 213 may be 1.08 mm or more, and may be spaced apart to have a spacing of 1.32 mm or less. Preferably, each of the plurality of first protrusions 123 may be spaced apart to have a spacing of 1.2 mm to protrude from the support member 211 of the coupling portion 210.

As described above, when each of the plurality of first protrusions 213 is spaced apart from each other and protrudes outward from the support member 211, the coupling unit 210 may be more rigidly coupled to the application unit 100. have. That is, when the coupling part 210 is inserted into the application part 100, the coupling part 210 may not be easily removed from the application part 100.

On the other hand, when the coupling part 210 is adhesively bonded to the application part 100 through a silicone adhesive, when the plurality of first protrusions 213 are provided on the support member 211, the plurality of first protrusions 213 The area to which the silicone adhesive is applied may be wider than when the support member 211 is not provided. Accordingly, the coupling portion 210 may be more firmly coupled to the application portion 100 through the silicone adhesive.

In addition, when the bonding part 210 is adhesively bonded to the application part 100 and the silicone adhesive, the silicone adhesive is applied on the support member 211 through the gap generated by the plurality of first protrusions 213 being spaced apart. You can prevent it from flowing down.

Meanwhile, each of the plurality of first protrusions 213 may be formed to have a diameter of 5.4 mm or more and 6.6 mm or less. Preferably, each of the plurality of first protrusions 213 may be formed to have a diameter of 6 mm.

Meanwhile, the coupling portion 210 may include a locking portion 214 under the plurality of first protrusions 213. The locking part 214 may be formed to protrude outward from the support member 211. In addition, the locking portion 214 may have an inclined surface inclined downward.

Meanwhile, the locking part 214 may have a triangular column shape. Specifically, the locking part 214 may have a triangular column shape in which a first surface and a second surface are right triangles.

That is, the locking part 214 has a triangular column shape in which the first and second surfaces are right-angled triangles, and a third surface existing between the first and second surfaces including a right-angled side among the right-angled triangles is coupled. It may have a shape in contact with the support member 211 of the part 210. In addition, an inclined surface may be provided in a direction opposite to the third surface.

When the support member 211 is provided with a locking portion 214, the therapist can prevent the detachment of the applicator 100, which may be caused by applying a force pulling the application device 1000 in the drug ward when treating the patient's oral cavity. I can. Therefore, the coupling part 210 may prevent damage to the mucous membrane in the oral cavity of the patient, which may occur due to the separation of the application part 100.

In addition, when the support member 211 is provided with a locking portion 214, when the therapist performs oral treatment of the patient, when rotating the application device 1000 in the drug ward, the support portion 200 is in the applicator 100 You can prevent idleness. That is, when the support member 211 is provided with the locking part 214, the application part 100 and the support part 200 can always rotate together.

That is, when the therapist rotates the application unit 1000 in the drug ward in order to clean the patient's oral cavity more cleanly or to more thoroughly apply the drug in the patient's oral cavity, the applicator 100 and the support ( 200) can always rotate together.

Meanwhile, according to some embodiments of the present disclosure, a plurality of locking portions 214 may be provided on the support member 211.

For example, referring to FIG. 3, one locking part 214 may be provided in one direction of the support member 211, and one more locking part 214 may be provided in a direction opposite to one direction. . However, the present invention is not limited thereto, and two or more locking portions 214 may be provided on the support member 211.

Further, referring again to FIGS. 3 to 5, the coupling part 210 may include a second protrusion 215 under the locking part 214. The second protrusion 215 may have a third diameter larger than the first diameter of the support member 211 and the second diameter of each of the plurality of first protrusions 213. Accordingly, the second protrusion 215 may protrude outward from the support member 211.

Specifically, the second protrusion 215 may be formed to have a diameter of 7.2 mm or more and 8.8 mm or less. Preferably, the second protrusion 215 may be formed to have a diameter of 8 mm. In addition, as described above in FIG. 2, the cut groove may be formed to have a length of 6.6 mm or more and 7.7 mm or less.

When the second protrusion 215 has a diameter of 8 mm, it may be longer than the length of the cut groove described above in FIG. 2. When the second protrusion 215 has a diameter as described above, even if the therapist applies a force to push the intraoral application device 1000 into the oral cavity when treating the patient's oral cavity, the applicator 100 is applied to the drug intraoral It may not be pushed downwards of the device 1000.

Accordingly, it is possible to prevent penetration, which may occur due to pushing, while the coupling part 210 is inserted into the coating part 100. Therefore, damage to the mucous membrane in the oral cavity of the patient can be prevented in advance.

According to some embodiments of the present disclosure, the handle part 300 coupled to the other end of the support part 200 may include a grip part 310 that prevents rotation when the user grips it. Here, the handle portion 300 may be formed to have a diameter of 5.4mm or more and 6.6mm or less. Preferably, the handle portion 300 may be formed to have a diameter of 6mm.

On the other hand, the grip part 310 may form a gripping part recessed to be curved so that the index finger and thumb are in close contact on both sides. As shown in FIG. 4, the grip part 310 may include a first gripping part 311 and a second gripping part 312 having a recessed shape.

Specifically, the grip part 310 may be formed such that a distance between the center points of the first gripping part 311 and the second gripping part 312 is 3.6mm or more and 4.4mm or less. Preferably, the grip portion 310 may be formed such that a distance between the center points of the first gripping part 311 and the second gripping part 312 is 4mm. Meanwhile, the grip part 310 may be formed such that a distance between the ends of the first gripping part 311 and the second gripping part 312 is 5.4mm or more and 6.6mm or less. Preferably, the grip part 310 may be formed such that a distance between the ends of the first gripping part 311 and the second gripping part 312 is 6mm. That is, the grip part 310 may be formed to have a shape having the thinnest central point and thicker toward both ends from the central point.

Therefore, the grip part 310, when the therapist treats the patient's oral cavity, the first gripping part 311 and the second gripping part 312 are in close contact with the index finger and thumb of the therapist, so that the application device 1000 ) Can be prevented from rotating differently from the therapist's intention. In addition, the grip part 310 may rotate the drug ward application device 1000 more accurately through the grip part when the therapist rotates the drug ward application device 1000.

6 is a view for explaining a method of coupling an applicator and a support included in a drug ward applicator according to some embodiments of the present disclosure.

Referring to FIG. 6, the application portion 100 may be inserted into and coupled to the coupling portion 210 of the support portion 200. Here, the application unit 100 may include an insertion unit 110. Specifically, the insertion portion 110 of the application portion 100 may include an insertion groove 111.

That is, the coupling part 210 of the support part 200 may be inserted into the insertion groove 111 of the application part 100.

Meanwhile, the depth of the cut groove 111 of the application part 100 may correspond to the length L3 of the coupling part provided in the support part 200. Specifically, the depth of the cut groove 111 may be the same as the length L3 of the coupling portion.

That is, the coupling portion 210 of the support portion 200 may be inserted into the cut groove 111 by the length of the insertion portion 110 of the application portion 100.

Therefore, the coupling portion 210 may not penetrate the application portion 100. In addition, it is possible to prevent the occurrence of damage to the mucous membrane in the oral cavity through one end of the support part 200 penetrating the application part.

The coupling part 210 provided at one end of the support part 200 may include a support member 211 having a first diameter.

In addition, the coupling part 210 may include a spherical member 212 at one end of the support member 211. When the spherical member 212 is provided at one end of the support member 211, it is possible to prevent damage to the mucous membrane in the patient's oral cavity when the therapist applies the medicine to the patient's oral cavity.

Specifically, even if the application portion 100 coupled to the coupling portion 210 is torn or separated, only the spherical member 212 provided at one end of the coupling portion 210 is exposed to the outside. Further, since the spherical member 212 does not have a sharp portion, even if the spherical member 212 is exposed, it is possible to prevent damage to the mucous membrane in the oral cavity of the patient when the therapist applies the medicine to the oral cavity of the patient.

On the other hand, the coupling part 210 may include a plurality of first protrusions 213. Here, the plurality of first protrusions 213 may be provided below the spherical member 212.

The number of the plurality of first protrusions 213 may be 2 to 4. However, the number of the plurality of first protrusions 213 is not limited thereto, and the number of the plurality of first protrusions 213 may be increased depending on the difficulty of manufacturing or the overall size of the application device 1000 in the drug ward.

In addition, each of the plurality of first protrusions 213 may have a second diameter larger than the first diameter of the support member 211. Accordingly, each of the plurality of first protrusions 213 may protrude outward from the support member 211.

In addition, each of the plurality of first protrusions 213 may be spaced apart from each other to have a specific interval. When each of the plurality of first protrusions 213 is spaced apart from each other and protrudes outward from the support member 211, the coupling part 210 may be more firmly coupled to the application part 100. That is, when the coupling part 210 is inserted into the application part 100, the coupling part 210 may not be easily removed from the application part 100.

Meanwhile, the coupling part 210 may be adhesively bonded to the insertion part 110 through a silicone adhesive while being inserted into the insertion groove 111 of the application part 100. Here, the silicone adhesive may be an adhesive in which silicon dioxide is mixed with methylpolysiloxane in a predetermined ratio. In this case, the silicone adhesive may have cold resistance, water crystal resistance, insulation, ozone resistance, low combustion, chemical inertness, and non-staining properties.

When the coupling part 210 is adhesively bonded to the application part 100 through a silicone adhesive, when the plurality of first protrusions 213 are provided on the support member 211, the plurality of first protrusions 213 are supported. The area where the silicone adhesive is applied may be wider than when the member 211 is not provided. Accordingly, the coupling portion 210 may be more firmly coupled to the application portion 100 through the silicone adhesive.

In addition, when the bonding part 210 is adhesively bonded to the application part 100 and the silicone adhesive, the silicone adhesive is applied on the support member 211 through the gap generated by the plurality of first protrusions 213 being spaced apart. You can prevent it from flowing down.

The coupling part 210 may include a locking part 214 under the plurality of first protrusions 213. The locking part 214 may be formed to protrude outward from the support member 211. In addition, the locking portion 214 may have an inclined surface inclined downward.

Meanwhile, the locking part 214 may have a triangular column shape. Specifically, the locking part 214 may have a triangular column shape in which a first surface and a second surface are right triangles.

That is, the locking part 214 has a triangular column shape in which the first and second surfaces are right-angled triangles, and a third surface existing between the first and second surfaces including a right-angled side among the right-angled triangles is coupled. It may have a shape in contact with the support member 211 of the part 210. In addition, an inclined surface may be provided in a direction opposite to the third surface.

When the support member 211 is provided with a locking portion 214, the therapist can prevent the detachment of the applicator 100, which may be caused by applying a force pulling the application device 1000 in the drug ward when treating the patient's oral cavity. I can. Therefore, the coupling part 210 may prevent damage to the mucous membrane in the oral cavity of the patient, which may occur due to the separation of the application part 100.

In addition, when the support member 211 is provided with a locking portion 214, when the therapist performs oral treatment of the patient, when rotating the application device 1000 in the drug ward, the support portion 200 is in the applicator 100 You can prevent idleness. That is, when the support member 211 is provided with the locking part 214, the application part 100 and the support part 200 can always rotate together.

That is, when the therapist rotates the application unit 1000 in the drug ward in order to clean the patient's oral cavity more cleanly or to more thoroughly apply the drug in the patient's oral cavity, the applicator 100 and the support ( 200) can always rotate together.

The coupling part 210 may include a second protrusion 215 under the locking part 214. The second protrusion 215 may have a first diameter of the support member 211 and a third diameter L2 larger than the second diameter L1 of each of the plurality of first protrusions 213. Accordingly, the second protrusion 215 may protrude outward from the support member 211.

Meanwhile, the cut groove 111 may be formed to have a length of 6.6 mm or more and 7.7 mm or less. For example, when the second protrusion 215 has a diameter of 8 mm, it may be longer than the length of the cut groove 111 described above.

When the second protrusion 215 has a diameter as described above, even if the therapist applies a force to push the intraoral application device 1000 into the oral cavity when treating the patient's oral cavity, the applicator 100 is applied to the drug intraoral It may not be pushed downwards of the device 1000.

Accordingly, it is possible to prevent penetration, which may occur due to pushing, while the coupling part 210 is inserted into the coating part 100. Therefore, damage to the mucous membrane in the oral cavity of the patient can be prevented in advance.

The description of the presented embodiments is provided to enable any person skilled in the art to make or use the present disclosure. Various modifications to these embodiments will be apparent to those of ordinary skill in the art, and general principles defined herein may be applied to other embodiments without departing from the scope of the present disclosure. Thus, the present disclosure is not limited to the embodiments presented herein, but is to be interpreted in the widest scope consistent with the principles and novel features presented herein.

Claims (12)

As a drug premises applicator,
An application portion having a polygonal column shape and having an insertion portion at a lower portion thereof;
A user-graspable handle portion; And
A support portion having a coupling portion inserted into the insertion portion at one end, and the other end opposite to the one end coupled to the handle portion;
Including,
The coupling part,
A support member having a first diameter;
A spherical member provided at one end of the support member;
A plurality of first protrusions provided below the spherical member and protruding from the support member so as to have a second diameter larger than the first diameter;
A locking portion provided below the plurality of first protrusions, protruding from the support member, and having an inclined surface inclined downward; And
A second protrusion provided below the locking part and protruding from the support member to have a third diameter larger than the second diameter;
Containing,
Applicator for drug premises.

The method of claim 1,
The insertion part,
Includes an incision groove cut to have a one (一) shape in the middle of the lower surface,
The depth of the cut groove corresponds to the length of the coupling portion,
Applicator for drug premises.
The method of claim 1,
The coupling part,
Adhesively bonded to the insertion part through a silicone adhesive in a state inserted into the insertion part,
Applicator for drug premises.
The method of claim 1,
The handle part,
Formed in a cylindrical shape having a fourth diameter larger than the diameter of the support,
Applicator for drug premises.

The method of claim 1,
The handle part,
When the user grips, the grip portion to prevent rotation;
Including,
The grip part,
Forming a gripping portion recessed to be curved so that the index finger and thumb adhere to both sides,
Applicator for drug premises.
The method of claim 1,
The application unit,
Made of a polyurethane (Polyurethane) material foam (Form), absorbing and discharging the solution of the drug,
Applicator for drug premises.
The method of claim 1,
The support part,
Made of a plastic material blended with 60 parts by weight of polycarbonate and 40 parts by weight of ABS resin (Acrylonitrile-Butadiene-Styrene Copolymer),
Applicator for drug premises.
The method of claim 2,
The incision groove,
Formed to have a length of 6.6 mm or more and 7.7 mm or less,
Applicator for drug premises.
The method of claim 1,
The support part,
It is formed to have a length of 139.5 mm or more and 170.5 mm or less,
3.6mm or more, formed to have a diameter of 4.4mm or less,
Applicator for drug premises.
The method of claim 1,
The user-graspable handle portion,
Formed to have a diameter of 5.4 mm or more and 6.6 mm or less,
Applicator for drug premises.
The method of claim 1,
The support member,
It is formed to have a diameter of 3.6 mm or more and 4.4 mm or less,
The spherical member,
It is formed to have a diameter of 5.4 mm or more and 6.6 mm or less,
The first protrusion,
It is formed to have a diameter of 5.4 mm or more and 6.6 mm or less,
The second protrusion,
7.2mm or more, formed to have a diameter of 8.8mm or less,
Applicator for drug premises.
The method of claim 1,
The plurality of first protrusions,
It is 1.08mm or more and is spaced apart to have a gap of 1.32mm or less and protrudes from the support member
Applicator for drug premises.

Images